Study Explores Epstein - Barr Virus and Multiple Sclerosis Link

Epstein-Barr virus (EBV) has been repeatedly associated with multiple sclerosis and other autoimmune diseases. A study supporting this link has found abnormal accumulation of EBV infected B lymphocytes in the brain lesions of patients with multiple sclerosis.

Multiple sclerosis is the most common inflammatory disease of the central nervous system affecting young adults. Similarly to other chronic inflammatory diseases, like rheumatoid arthritis and systemic lupus erythematosus, multiple sclerosis is thought to result from an inappropriate attack of the immune system toward selected body components, a process named autoimmunity. In the case of multiple sclerosis, the immune system is thought to attack myelin, the lipid-rich sheath coating our nerves.

Image: Photomicrograph depicting leukemia cells that contain Epstein Barr virus.

To date neither the causes nor the cure of multiple sclerosis have been identified. Viruses have always attracted the interest of immunologists as possible triggers of autoimmune diseases due to their ability to interfere with the host’s immune system. EBV infects up to 95 % of the human population worldwide and has been repeatedly associated with multiple sclerosis through epidemiological and serological studies. The virus has the ability to hide in a particular population of immune cells, the B lymphocytes, remaining in a relatively dormant state for the entire life of the host. However, when not properly controlled by the immune system, EBV can reactivate causing tumors.

The researchers showed that EBV is present in brain lesions of patients with multiple sclerosis and that the virus is brought into the central nervous system by B lymphocytes, which behave as Trojan horses for the virus. They also showed that the infected B cells present in the brain become the target of an immune attack, thus promoting the chronic inflammation which leads to tissue destruction. This raises the suspicion that EBV and its Trojan horses are the main cause of brain damage in multiple sclerosis.

The researchers conclude that by shedding light on the involvement of EBV in multiple sclerosis, the findings will pave the way to disease prevention and future treatments.
References:
1. Salvetti M, Giovannoni G, Aloisi F. Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol. 2009 Jun;22(3):201-6. PMID: 19359987.

Researchers Discover Possible Onset Mechanism for Multiple Sclerosis

Researchers explain that a non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how

Researchers Make Multiple Sclerosis Genetic Discovery

Australian and New Zealand researchers have discovered two new locations of genes in multiple sclerosis which could help to unravel the causes of the disease and other autoimmune diseases.

Study Provides Blueprint for Stem Cell Treatment of Multiple Sclerosis

By discovering how adult neural stem cells navigate to injury sites in the central nervous system, researchers have helped solve a puzzle in the creation of stem cell-based treatments: How do

Blood Test Provides Simpler Approach to Monitor Multiple Sclerosis

According to a study, serum DNA blood tests can be used to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis.

Statins Could Have a Negative Impact in Multiple Sclerosis Patients

According to researchers at the Montreal Neurological Institute, statins, a commonly prescribed class of drugs used by millions worldwide to lower blood cholesterol levels, could actually have